Global Seborrheic Keratosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4564297
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Cortex Technology ApS
  • CryoConcepts LP
  • Cryoswiss GmbH
  • DRE Medical, Inc.
  • EpiPharm AG
  • H&O Equipments SA
  • MORE
Seborrheic Keratosis Treatment Market - Growth, Future Prospects and Competitive Analysis, 2018-2026, the global seborrheic keratosis treatment market expected to reach US$ 1,320.8 Mn by 2026.

Market Insights
The global seborrheic keratosis treatment market expected to reach US$ 1,320.8 Mn by 2026. Seborrheic keratosis is one of the most common benign skin growths in adults and its prevalence rises with the increasing age. These growths are normally painless and can be left untreated; however, they could be bothersome depending on size and location, and for aesthetic or cosmetic reasons. The exact cause of seborrheic keratosis is unknown, yet the incidence is directly proportional with advancing age. Seborrheic keratosis also tends to run in heredity. In 2014, seborrheic keratosis was estimated to affect 83 million people and dermatologists reported an average diagnosis of 155 patients per month with the disease in the United States.

Growing preference for cosmetic and aesthetic quotient and high prevalence of seborrheic keratosis are observed to be the key factors driving the seborrheic keratosis treatment market. Although surgical treatments are available in the market to treat seborrheic keratosis, a topical solution (40% hydrogen peroxide – Eskata by Aclaris Therapeutics) is approved by the FDA in 2017, which may augment the market growth due to expected improvement in treatment adherence. Furthermore, Aclaris Therapeutics has also filed an application in the European regulatory agencies for approval. The approval of the topical solution along with the ongoing research for other therapeutics will contribute to the growth of the seborrheic keratosis treatment market during the forecast period.

The global seborrheic keratosis treatment market is segmented into surgical treatments and topical solution treatments. Surgical treatments segment is further categorized into cryosurgery, electrocautery, curettage, and laser ablation. Topical solution treatment segment includes the currently approved 40% hydrogen peroxide solution. While destructive treatments such as cryotherapy and curettage will remain the gold standard for seborrheic keratosis treatment, new therapies such as laser beam treatment and topical applications are anticipated to achieve more efficiency with comfort and convenience for patients.
Based on geographical segmentation, North America dominated the global market with more than 30% market share in 2017, and projected to hold its dominance during the forecast period. High prevalence of seborrheic keratosis and adoption of advanced treatment technologies in the region drives the North America market. Asia Pacific and Latin America markets are anticipated to experience the fastest growth during the forecast period owing to phenomenal growth in demand for skin care and aesthetic products in the regions. The key players in the seborrheic keratosis treatment market include Aclaris Therapeutics, Inc., Cortex Technology ApS, CryoConcepts LP, Cryoswiss GmbH, EpiPharm AG, DRE Medical, Inc., H&O Equipments SA, Orasure Technologies, Inc., Special Medical Technology Co., Ltd., and Wallach Surgical Devices, Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cortex Technology ApS
  • CryoConcepts LP
  • Cryoswiss GmbH
  • DRE Medical, Inc.
  • EpiPharm AG
  • H&O Equipments SA
  • MORE
Chapter 1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I - Secondary Research
1.4.2. Phase II - Primary Research
1.4.3. Phase III - Expert Panel Review
1.4.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Seborrheic Keratosis Treatment Market Portraiture
2.2. Global Seborrheic Keratosis Treatment Market, by Treatment Type, 2017 (US$ Mn)
2.3. Global Seborrheic Keratosis Treatment Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Seborrheic Keratosis Treatment Market: Market Dynamics and Future Outlook
3.1. Overview
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Growing Prevalence of Seborrheic Keratosis
3.2.1.2. Driver 2
3.2.2. Challenges
3.2.2.1. Challenge 1
3.2.2.2. Challenge 2
3.2.3. Opportunities
3.2.3.1. Opportunity 1
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Surgical Treatment
4.2.1. Cryosurgery
4.2.2. Electrocautery
4.2.3. Curettage
4.2.4. Laser Ablation
4.3. Topical Solution Treatment
4.3.1. Hydrogen Peroxide 40% Solution (Eskata)
4.4. Pipeline Drugs (Qualitative Information)
4.4.1. EPI SK14 (EpiPharm AG)

Chapter 5. Global Seborrheic Keratosis Treatment Market, by Geography, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. North America Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.2.1. North America Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.2.2. North America Seborrheic Keratosis Treatment Market, by Country, 2016 - 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.3.1. Europe Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.3.2. Europe Seborrheic Keratosis Treatment Market, by Country/Region, 2016 - 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.4.1. Asia Pacific Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.4.2. Asia Pacific Seborrheic Keratosis Treatment Market, by Country/Region, 2016 - 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of APAC
5.5. Latin America Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.5.1. Latin America Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.5.2. Latin America Seborrheic Keratosis Treatment Market, by Country/Region, 2016 - 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.6.1. Middle East & Africa Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.6.2. Middle East & Africa Seborrheic Keratosis Treatment Market, by Region, 2016 - 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Aclaris Therapeutics, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Cortex Technology ApS
6.3. CryoConcepts LP
6.4. Cryoswiss GmbH
6.5. DRE Medical, Inc.
6.6. EpiPharm AG
6.7. H&O Equipments SA
6.8. Orasure Technologies, Inc.
6.9. Special Medical Technology Co., Ltd.
6.10. Wallach Surgical Devices, Inc.

List of Figures
FIG. 1 Market Segmentation: Global Seborrheic Keratosis Treatment Market
FIG. 2 Research Methodology: Global Seborrheic Keratosis Treatment Market
FIG. 3 Global Seborrheic Keratosis Treatment Market, by Treatment Type, 2017 (US$ Mn)
FIG. 4 Global Seborrheic Keratosis Treatment Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition: Global Seborrheic Keratosis Treatment Market, by Geography, 2017
FIG. 6 Competitive Landscape, by Key Players, 2017
FIG. 7 Global Cryosurgery Market for Seborrheic Keratosis Treatment, 2016 - 2026 (US$ Mn)
FIG. 8 Global Electrocautery Market for Seborrheic Keratosis Treatment, 2016 - 2026 (US$ Mn)
FIG. 9 Global Curettage Market for Seborrheic Keratosis Treatment, 2016 - 2026 (US$ Mn)
FIG. 10 Global Laser Ablation Market for Seborrheic Keratosis Treatment, 2016 - 2026 (US$ Mn)
FIG. 11 Global Hydrogen Peroxide 40% Solution (Eskata) Market for Seborrheic Keratosis Treatment, 2016 - 2026 (US$ Mn)
FIG. 12 U.S. Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 13 Canada Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 14 U.K. Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 15 Germany Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 16 Rest of Europe Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 17 Japan Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 18 China Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 19 Rest of Asia Pacific Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 20 Brazil Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 21 Mexico Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 22 Rest of Latin America Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 23 GCC Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
FIG. 24 Rest of Middle East and Africa Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)

List of Tables
TABLE 1. Global Seborrheic Keratosis Treatment Market Portraiture
TABLE 2. Global Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
TABLE 3. Global Seborrheic Keratosis Treatment Market, by Geography, 2016 - 2026 (US$ Mn)
TABLE 4. Global Surgical Treatments Market for Seborrheic Keratosis, by Type, 2016 - 2026 (US$ Mn)
TABLE 5. Global Topical Solution Market for Seborrheic Keratosis Treatment, by Type, 2016 - 2026 (US$ Mn)
TABLE 6. North America Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
TABLE 7. North America Seborrheic Keratosis Treatment Market, by Country, 2016 - 2026 (US$ Mn)
TABLE 8. Europe Seborrheic Keratosis Treatment Market, by Type, 2016 - 2026 (US$ Mn)
TABLE 9. Europe Seborrheic Keratosis Treatment Market, by Country, 2016 - 2026 (US$ Mn)
TABLE 10. Asia Pacific Seborrheic Keratosis Treatment Market, by Type, 2016 - 2026 (US$ Mn)
TABLE 11. Asia Pacific Seborrheic Keratosis Treatment Market, by Country, 2016 - 2026 (US$ Mn)
TABLE 12. Latin America Seborrheic Keratosis Treatment Market, by Type, 2016 - 2026 (US$ Mn)
TABLE 13. Latin America Seborrheic Keratosis Treatment Market, by Country, 2016 - 2026 (US$ Mn)
TABLE 14. Middle East and Africa Seborrheic Keratosis Treatment Market, by Type, 2016 - 2026 (US$ Mn)
TABLE 15. Middle East and Africa Seborrheic Keratosis Treatment Market, by Region, 2016 - 2026 (US$ Mn)
TABLE 16. Aclaris Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17. Cortex Technology ApS: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18. CryoConcepts LP.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19. Cryoswiss GmbH.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20. DRE Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21. EpiPharm AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22. H&O Equipments SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23. Orasure Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24. Special Medical Technology Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25. Wallach Surgical Devices, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Aclaris Therapeutics, Inc.
  • Cortex Technology ApS
  • CryoConcepts LP
  • Cryoswiss GmbH
  • DRE Medical, Inc.
  • EpiPharm AG
  • H&O Equipments SA
  • Orasure Technologies, Inc.
  • Special Medical Technology Co., Ltd.
  • Wallach Surgical Devices, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll